We are live on ! Find out more
YIH

Y-Intercept (HK) Portfolio holdings

AUM $5.05B
1-Year Est. Return 17.89%
This Fund
S&P 500
This Quarter Est. Return
+13.21%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
AUM
$1.07B
AUM Growth
+$51.2M
Cap. Flow
-$43M
Cap. Flow %
-4.01%
Top 10 Hldgs %
8.18%
Holding
1,747
New
747
Increased
219
Reduced
207
Closed
574

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$12.1M
2
AAPL icon
Apple
AAPL
+$8.41M
3
MSI icon
Motorola Solutions
MSI
+$7.68M
4
JD icon
JD.com
JD
+$7.3M
5
ITW icon
Illinois Tool Works
ITW
+$6.58M

Top Sells

Rank Stock Value
1
BX icon
Blackstone
BX
+$11.4M
2
KVUE icon
Kenvue
KVUE
+$8.1M
3
RTX icon
RTX Corp
RTX
+$7.61M
4
CSCO icon
Cisco
CSCO
+$6.72M
5
ADBE icon
Adobe
ADBE
+$6.58M

Sector Composition

Rank Sector Weight
1 Technology 16.62%
2 Financials 15.83%
3 Consumer Discretionary 13.61%
4 Healthcare 10.98%
5 Industrials 10.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HNST icon
1101
The Honest Company
HNST
$427M
$92.8K 0.01%
+28,114
New +$51.3K
RLX icon
1102
RLX Technology
RLX
$2.43B
$92.3K 0.01%
+46,156
New +$85.8K
APLD icon
1103
Applied Digital
APLD
$7.55B
$92K 0.01%
+13,645
New +$73.4K
PRME icon
1104
Prime Medicine
PRME
$553M
$90.3K 0.01%
+10,193
New +$78.5K
LNKB
1105
DELISTED
LINKBANCORP
LNKB
$89.5K 0.01%
+11,225
New +$74.1K
QURE icon
1106
uniQure
QURE
$2.45B
$89.2K 0.01%
+13,180
New +$87.1K
INVE icon
1107
Identive
INVE
$64.1M
$89.2K 0.01%
+10,825
New +$76.4K
ALDX icon
1108
Aldeyra Therapeutics
ALDX
$95.3M
$89K 0.01%
+25,354
New +$78.2K
AMTX icon
1109
Aemetis
AMTX
$106M
$88.1K 0.01%
+16,822
New +$79.5K
KOPN icon
1110
Kopin
KOPN
$645M
$88.1K 0.01%
+43,407
New +$62K
TCRX icon
1111
TScan Therapeutics
TCRX
$49.8M
$87.5K 0.01%
+15,005
New +$68.7K
ABSI icon
1112
Absci
ABSI
$1.22B
$87.4K 0.01%
+20,807
New +$38.6K
LAB icon
1113
Standard BioTools
LAB
$305M
$87.3K 0.01%
+39,508
New +$84.3K
LTRX icon
1114
Lantronix
LTRX
$236M
$86.2K 0.01%
+14,713
New +$74K
AGEN
1115
Agenus
AGEN
$266M
$86.2K 0.01%
+5,205
New +$86.2K
COGT icon
1116
Cogent Biosciences
COGT
$6.83B
$86K 0.01%
+14,618
New +$112K
IVVD icon
1117
Invivyd
IVVD
$175M
$85.7K 0.01%
+21,746
New +$41.1K
BLZE icon
1118
Backblaze
BLZE
$718M
$85.5K 0.01%
+11,260
New +$71.1K
WOOF icon
1119
Petco
WOOF
$802M
$85.1K 0.01%
26,919
-173,680
-87% -$600K
LFCR icon
1120
Lifecore Biomedical
LFCR
$165M
$84.7K 0.01%
+13,685
New +$95K
NNBR icon
1121
NN Inc
NNBR
$265M
$84.7K 0.01%
+21,164
New +$50.3K
BVS icon
1122
Bioventus
BVS
$883M
$84.5K 0.01%
+16,038
New +$63.5K
RDNW
1123
RideNow Group
RDNW
$252M
$83.3K 0.01%
+10,232
New +$65.6K
SACH
1124
Sachem Capital Corp
SACH
$38.8M
$82.7K 0.01%
+22,117
New +$79K
OUST icon
1125
Ouster
OUST
$2.26B
$82.1K 0.01%
+10,701
New +$56.1K

Similar funds

Y-Intercept (HK)'s Q4 2023 Portfolio in Review

As of Q4 2023, Y-Intercept (HK) held 1,747 positions worth $1.07B, up 5% from $1.02B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.

Y-Intercept (HK) withdrew a net $43M in Q4 2023, closing 574 positions and reducing 207 holdings. Its most notable exit was Blackstone, an estimated $11.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Y-Intercept (HK) opened a new position in Merck worth $12.7M.

  • Y-Intercept (HK)'s largest Q4 2023 buy was Merck: 116,714 shares worth $12.7M.
  • Y-Intercept (HK) added most to Apple in Q4 2023, an estimated $8.41M increase.
  • Y-Intercept (HK)'s biggest Q4 2023 reduction was Kenvue, cutting an estimated $8.1M.
  • Y-Intercept (HK) fully exited Blackstone in Q4 2023, selling an estimated $11.4M.
  • Y-Intercept (HK)'s ten largest holdings make up 8.2% of its $1.07B portfolio in Q4 2023.
  • Y-Intercept (HK) opened 747 new positions and closed 574 in Q4 2023.
  • Y-Intercept (HK)'s portfolio value rose 5% quarter-over-quarter to $1.07B.

Based on Y-Intercept (HK)'s 13F filing for Q4 2023, filed 13 Feb 2024.